By Robert N. Klein and David Bluestone, Americans for Stem Cell Therapies and Cures

San Francisco is the benevolent host to California’s surrogate national stem cell program; it stands in sharp contrast to the inactivity (and intolerance) of the federal government.  California’s stem cell program has created a new model for how to fund medical research in this country. Scientific and medical research is effectively the most important intellectual capital investment and asset of this society and must be funded with long term capital debt instruments. By making long term investments in today’s intellectual property, the California Institute for Regenerative Medicine is investing in our society’s health in the future. Read more »